Markets:

Overview

News

Currencies

International

Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

76.52 -1.56 (-2.00%)

Streaming Delayed Price Updated: 11:38 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

3 Small-Cap Stocks That Are Worth the Gamble ↗

July 04, 2023

Although these small-cap stock picks may not be household names, they command significant upside potential for daring speculators.

Via InvestorPlace

Abcam Stock Earns Relative Strength Rating Upgrade ↗

June 20, 2023

A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance.

Via Investor's Business Daily

FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

June 06, 2023

On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier.

Via Investor's Business Daily

Overview Of Value Stocks In The Healthcare Sector ↗

June 05, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 22, 2023

Via Benzinga

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

January 09, 2023

Via Benzinga

Kiniksa Inks Global License Agreement With Roche For Vixarelimab ↗

August 03, 2022

Via Benzinga

Recap: Kiniksa Pharmaceuticals Q1 Earnings ↗

May 03, 2022

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

7 Small-Cap Stocks to Buy for Explosive Growth Potential ↗

March 30, 2023

Although small-cap stocks to buy presents higher risks than the large caps, the segment also enjoys critical advantages.

Via InvestorPlace

7 Dirt-Cheap Stocks Sitting in the Sweet Spot ↗

March 23, 2023

These cheap stocks don’t just attract on the ticker tape but rather feature compelling fundamentals and analysts’ upside projections.

Via InvestorPlace

The Top 7 Growth Stocks in Biotech ↗

March 03, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Via InvestorPlace

Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗

November 02, 2022

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Recap: Kiniksa Pharmaceuticals Q3 Earnings ↗

November 01, 2022

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Kiniksa...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 24, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Kiniksa Pharmaceuticals: Q2 Earnings Insights ↗

August 03, 2022

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q2 earnings results on Wednesday, August 3, 2022. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Week In Review: Huadong Pharma Enters $662 Million Deal For Two Kiniksa Anti-Inflammatory Drugs ↗

February 26, 2022

Huadong Pharma announced a $662 million agreement to develop two Kiniksa Pharma anti-inflammatory drug candidates in southeast Asia (ex-Japan). Huadong will pay $22 million and be responsible for up to...

Via Talk Markets

Kiniksa Pharma, Huadong Medicine Ink Licensing Pact For Arcalyst, Mavrilimumab ↗

February 22, 2022

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd., a subsidiary of Huadong Medicine Co., Ltd., have announced a strategic...

Via Benzinga

Kiniksa Pharmaceuticals: Q4 Earnings Insights ↗

February 22, 2022

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

December 29, 2021

Tigress Financial lifted the price target on McDonald's Corporation (NYSE:

Via Benzinga

Why Kiniksa Pharmaceuticals Stock Is Falling Today ↗

December 28, 2021

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) is trading lower Tuesday morning after the company announced the Phase 3 trial of mavrilimumab in COVID-19-related ARDS did not...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 28, 2021

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1...

Via Benzinga

71 Biggest Movers From Yesterday ↗

November 03, 2021

Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide ↗

November 02, 2021

Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,063.98 while the NASDAQ rose 0.03% to 15,600.42. The S&P also rose, gaining 0.28% to 4,626.45. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 02, 2021

Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

All News about Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

Starting at /week.